← Leaderboards
Anne E Chiaramello
George Washington University
$5,221,637
Attributed
$7,190,784
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $957.1K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,190,784 · 4
By mechanism
UH3$2,806,464 · 1
R01$2,443,266 · 1
UG3$1,131,831 · 1
R21$809,223 · 1
Top collaborators
- Andrea Lynne Gropman3 shared
- Debra S Regier2 shared
Others in their field
Top investigators on “Future”
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$274,284,003
- Chanza Baytop · Westat, Inc.$271,217,917
- Everette D Joseph · Howard University$246,289,043
Research focus
FuturePropertyNeurodegenerative DisordersCessation Of LifeNeuronsLeadMetabolismResearch PersonnelProgramsDesignUnited States National Institutes Of HealthGene ExpressionApoptosisPc12 CellsNeurogenesisBaseGenesRegulationStagingPathway InteractionsNovel TherapeuticsPreventMediatingCells
Grant awards (18)
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies$916,686
UH3 · FY2025 · TR · contact PI
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies$932,694
UH3 · FY2024 · TR · contact PI
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies$957,084
UH3 · FY2023 · TR · contact PI
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies$557,017
UG3 · FY2022 · TR · contact PI
Emerging therapeutic candidates for rare maternally inherited mitochondrial diseases with shared etiologies$574,814
UG3 · FY2021 · TR · contact PI
A Pharmaco-Epigenomic Intervention for the Mitochondrial Disorder MELAS$400,869
R21 · FY2016 · NS · contact PI
A Pharmaco-Epigenomic Intervention for the Mitochondrial Disorder MELAS$408,354
R21 · FY2015 · NS · contact PI
Transcriptional Dynamics of Neuronal Survival$76,405
R01 · FY2010 · NS · contact PI
Transcriptional Dynamics of Neuronal Survival$394,623
R01 · FY2009 · NS · contact PI
Transcriptional Dynamics of Neuronal Survival$12,467
R01 · FY2009 · NS · contact PI
Transcriptional Dynamics of Neuronal Survival$320,332
R01 · FY2008 · NS · contact PI
Transcriptional Dynamics of Neuronal Survival$60,180
R01 · FY2008 · NS · contact PI
Transcriptional Dynamics of Neuronal Survival$310,000
R01 · FY2007 · NS · contact PI
Transcriptional Dynamics of Neuronal Differentiation$25,000
R01 · FY2006 · NS · contact PI
Transcriptional Dynamics of Neuronal Differentiation$304,000
R01 · FY2004 · NS
Transcriptional Dynamics of Neuronal Differentiation$304,000
R01 · FY2003 · NS
Transcriptional Dynamics of Neuronal Differentiation$304,000
R01 · FY2002 · NS
Transcriptional Dynamics of Neuronal Differentiation$332,259
R01 · FY2001 · NS